(Q47380939)

English

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

scientific article published on 21 November 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

1 reference

based on heuristic

inferred from title

author name string

L Cavalleri

1

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

E Merlo Pich

2

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

M J Millan

3

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

C Chiamulera

4

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

T Kunath

5

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

P F Spano

6

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

G Collo

7

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

language of work or name

0 references

publication date

21 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

Molecular Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

https://scigraph.springernature.com/pub.10.1038/mp.2017.241

0 references

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The use of ketamine as an antidepressant: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Structural and synaptic plasticity in stress-related disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The mesolimbic dopamine reward circuit in depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Lower dopamine transporter binding potential in striatum during depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Pluripotent stem cells in disease modelling and drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: a double immunocytochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

AMPA glutamate receptor subunits 1 and 2 regulate dendrite complexity and spine motility in neurons of the developing neocortex

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Chronic Ampakine Treatments Stimulate Dendritic Growth and Promote Learning in Middle-Aged Rats

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Effects of a ketamine metabolite on synaptic NMDAR function.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Chronic elevation of brain-derived neurotrophic factor by ampakines

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

BDNF - a key transducer of antidepressant effects.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Essential Role of Mesolimbic Brain-Derived Neurotrophic Factor in Chronic Social Stress-Induced Depressive Behaviors

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

21 January 2018

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466

1 reference

https://api.crossref.org/works/10.1038%2FMP.2017.241

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A

1 reference

https://pubmed.ncbi.nlm.nih.gov/29158584

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29158584

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/29158584

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BDNF release is required for the behavioral actions of ketamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/29158584

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29158584

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MP.2017.241

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/29158584

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47380939&oldid=2154555594"